APL-UW Home

Jobs
About
Campus Map
Contact
Privacy
Intranet

Vera Khokhlova

Senior Principal Engineer

Email

verak2@uw.edu

Phone

206-221-6585

Education

M.S. Physics, Moscow State University, 1986

Ph.D. Acoustics, Moscow State University, 1991

Videos

Ultrasonic tweezers: Technology to lift and steer solid objects in a living body

In a recent paper, a CIMU team describes successful experiments to manipulate a solid object within a living body with ultrasound beams transmitted through the skin.

More Info

15 Jul 2020

A collaborative, international research teams developed and tuned an ultrasound transducer to create vortex shaped beams that can trap, grab, levitate, and move in three dimensions mm-scale objects. The team is working to apply this technology to their all-in-one kidney stone treatment system that, in clinical trials, uses ultrasound to non-invasively break, erode, and move stones and stone fragments out of the kidney so that they may pass naturally from the body.

Mechanical Tissue Ablation with Focused Ultrasound

An experimental noninvasive surgery method uses nonlinear ultrasound pulses to liquefy tissue at remote target sites within a small focal region without damaging intervening tissues. A multi-institution, international team led by CIMU researchers is applying the method to the focal treatment of prostate tumors.

More Info

19 Mar 2020

Boiling histotripsy utilizes sequences of millisecond-duration HIFU pulses with high-amplitude shocks that form at the focus by nonlinear propagation effects. Due to strong attenuation of the ultrasound energy at the shocks, these nonlinear waves rapidly heat tissue and generate millimeter-sized boiling bubbles at the focus within each pulse. Then the further interaction of subsequent shocks with the vapor cavity causes tissue disintegration into subcellular debris through the acoustic atomization mechanism.

The method was proposed at APL-UW in collaboration with Moscow State University (Russia) and now is being evaluated for various clinical applications. It has particular promise because of its important clinical advantages: the treatment of tissue volumes can be accelerated while sparing adjacent structures and not injuring intervening tissues; it generates precisely controlled mechanical lesions with sharp margins; the method can be implemented in existing clinical systems; and it can be used with real-time ultrasound imaging for targeting, guidance, and evaluation of outcomes. In addition, compared to thermal ablation, BH may lead to faster resorption of the liquefied lesion contents.

Characterizing Medical Ultrasound Sources and Fields

For every medical ultrasound transducer it's important to characterize the field it creates, whether for safety of imaging or efficacy of therapy. CIMU researchers measure a 2D acoustic pressure distribution in the beam emanating from the source transducer and then reconstruct mathematically the exact field on the surface of the transducer and in the entire 3D space.

11 Sep 2017

Publications

2000-present and while at APL-UW

Advancing boiling histotripsy dose in ex vivo and in vivo renal tissues via quantitative histological analysis and shear wave elastography

Ponomarchuk, E., G. Thomas, M. Song, Y.-N. Wang, S. Totten, G. Schade, J. Thiel, M. Bruce, V. Khokhlova, and T. Khokhlova, "Advancing boiling histotripsy dose in ex vivo and in vivo renal tissues via quantitative histological analysis and shear wave elastography," Ultrasound Med. Biol., 50, 1936-1944, doi:10.1016/j.ultrasmedbio.2024.08.022, 2024.

More Info

1 Dec 2024

Objective
In the context of developing boiling histotripsy (BH) as a potential clinical approach for non-invasive mechanical ablation of kidney tumors, the concept of BH dose (BHD) was quantitatively investigated in porcine and canine kidney models in vivo and ex vivo.

Methods
Volumetric lesions were produced in renal tissue using a 1.5-MHz 256-element HIFU-array with various pulsing protocols: pulse duration tp = 1–10 ms, number of pulses per point ppp = 1–15. Two BHD metrics were evaluated: BHD1 = ppp, BHD2 = tp × ppp. Quantitative assessment of lesion completeness was performed by their histological analysis and assignment of damage score to different renal compartments (i.e., cortex, medulla, and sinus). Shear wave elastography (SWE) was used to measure the Young's modulus of renal compartments in vivo vs ex vivo, and before vs after BH treatments.

Results
In vivo tissue required lower BH doses to achieve identical degree of fractionation as compared to ex vivo. Renal cortex (homogeneous, low in collagen) was equal or higher in stiffness than medulla (anisotropic, collagenous), 5.8–12.2 kPa vs 4.7–9.6 kPa, but required lower BH doses to be fully fractionated. Renal sinus (fatty, irregular, with abundant collagenous structures) was significantly softer ex vivo vs in vivo, 4.9–5.1 kPa vs 9.7–15.2 kPa, but was barely damaged in either case with any tested BH protocols. BHD1 was shown to be relevant for planning the treatment of renal cortex (sufficient BHD1 = 5 pulses in vivo and 10 pulses ex vivo), while none of the tested doses resulted in complete fractionation of medulla or sinus. Post-treatment SWE imaging revealed reduction of tissue stiffness ex vivo by 27–58%, increasing with the applied dose, and complete absence of shear waves within in vivo lesions, both indicative of tissue liquefaction.

Conclusion
The results imply that tissue resistance to mechanical fractionation, and hence required BH dose, are not solely determined by tissue stiffness but also depend on its composition and structural arrangement, as well as presence of perfusion. The SWE-derived reduction of tissue stiffness with increasing BH doses correlated with tissue damage score, indicating potential of SWE for post-treatment confirmation of BH lesion completeness.

Histotripsy: A method for mechanical tissue ablation with ultrasound

Xu, Z., T.D. Khokhlova, C.S. Cho, and V.A. Khokhlova, "Histotripsy: A method for mechanical tissue ablation with ultrasound," Ann. Rev. Biomed. Eng., 26, 141-167, doi:10.1146/annurev-bioeng-073123-022334, 2024.

More Info

1 Jul 2024

Histotripsy is a relatively new therapeutic ultrasound technology to mechanically liquefy tissue into subcellular debris using high-amplitude focused ultrasound pulses. In contrast to conventional high-intensity focused ultrasound thermal therapy, histotripsy has specific clinical advantages: the capacity for real-time monitoring using ultrasound imaging, diminished heat sink effects resulting in lesions with sharp margins, effective removal of the treated tissue, a tissue-selective feature to preserve crucial structures, and immunostimulation. The technology is being evaluated in small and large animal models for treating cancer, thrombosis, hematomas, abscesses, and biofilms; enhancing tumor-specific immune response; and neurological applications. Histotripsy has been recently approved by the US Food and Drug Administration to treat liver tumors, with clinical trials undertaken for benign prostatic hyperplasia and renal tumors. This review outlines the physical principles of various types of histotripsy; presents major parameters of the technology and corresponding hardware and software, imaging methods, and bioeffects; and discusses the most promising preclinical and clinical applications.

Elastic properties of aging human hematoma model in vitro and its susceptibility to histotripsy liquefaction

Ponomarchuk, E.M., and 12 others including T.D. Khokhlova, O.A. Sapozhnikov, and V.A. Khokhlova, "Elastic properties of aging human hematoma model in vitro and its susceptibility to histotripsy liquefaction," Ultrasound Med. Biol., 50, 927-938, doi:10.1016/j.ultrasmedbio.2024.02.019, 2024.

More Info

1 Jun 2024

Tissue susceptibility to histotripsy disintegration has been reported to depend on its elastic properties. This work was aimed at investigation of histotripsy efficiency for liquefaction of human hematomas, depending on their stiffness and degree of retraction over time (0–10 d).

It was found that clotting time decreased from 113 to 25 min with the increase in blood temperature from 10°C to 37°C. The shear modulus increased to 0.53 ± 0.17 kPa during clotting and remained constant within 8 d of incubation at 2°C. Sample volumes decreased by 57% because of retraction within 10 d. SEM revealed significant echinocytosis but unchanged ultrastructure of the fibrin meshwork. Liquefaction rate and lesion dimensions produced with the same histotripsy protocols correlated with the increase in the degree of retraction and were lower in retracted samples versus freshly clotted samples. More than 80% of residual fibrin fragments after histotripsy treatment were shorter than 150 μm; the maximum length was 208 μm, allowing for unobstructed aspiration of the lysate with most clinically used needles.

The results indicate that hematoma susceptibility to histotripsy liquefaction is not entirely determined by its stiffness, and correlates with the retraction degree.

More Publications

Inventions

Transrectal Ultrasound Probe for Boiling Histotripsy Ablation of Prostate, and Associated Systems and Methods

Inventors: V. Khokhlova, P. Rosnitskiy (Seattle), P.V. Yuldashev (Moscow), T.D. Khokhlova (Seattle), O. Sapozhnikov, and G.R. Schade (Seattle)

Patent Number: 11,896,853

Vera Khokhlova, Oleg Sapozhnikov

Patent

13 Feb 2024

High Intensity Focused Ultrasound Systems for Treating Tissue

Inventors: Y.-N. Wang, M.R. Bailey, T.D. Khokhlova (Seattle), W. Kreider, A.D. Maxwell, G.R. Schade (Seattle), and V.A. Khokhlova

Patent Number: 11,857,813

Yak-Nam Wang, Mike Bailey, Wayne Kreider, Adam Maxwell, Vera Khokhlova

Patent

2 Jan 2024

MRI-Feedback Control of Ultrasound Based Mechanical Fractionation of Biological Tissue

Patent Number: 11,224,356

Wayne Kreider, Vera Khokhlova

More Info

Patent

18 Jan 2022

Disclosed herein are example embodiments of devices, systems, and methods for mechanical fractionation of biological tissue using magnetic resonance imaging (MRI) feedback control. The examples may involve displaying an image representing first MRI data corresponding to biological tissue, and receiving input identifying one or more target regions of the biological tissue to be mechanically fractionated via exposure to first ultrasound waves. The examples may further involve applying the first ultrasound waves and, contemporaneous to or after applying the first ultrasound waves, acquiring second MRI data corresponding to the biological tissue. The examples may also involve determining, based on the second MRI data, one or more second parameters for applying second ultrasound waves to the biological tissue, and applying the second ultrasound waves to the biological tissue according to the one or more second parameters.

More Inventions

Acoustics Air-Sea Interaction & Remote Sensing Center for Environmental & Information Systems Center for Industrial & Medical Ultrasound Electronic & Photonic Systems Ocean Engineering Ocean Physics Polar Science Center
Close

 

Close